Replies to post #243850 on Biotech Values

[DewDiligence]

LSTA acquired by_private company_for $4.00/sh cash+CVR—an 85% premium to yesterday’s close (excluding the CVR):

https://www.globenewswire.com/news-release/2026/01/21/3222654/18623/en/Lisata-Therapeutics-Enters-Into-Term-Sheet-to-be-Acquired-by-Kuva-Labs-for-4-00-Per-Share-in-an-All-Cash-Tender-Offer.html

The buyer is Kuva Labs from Ann Arbor, MI. The deal value (excluding the CVR) is approximately $40M.